Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 551 to 575 of 2545

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Avatrombopag for treating primary chronic immune thrombocytopeniaTA853
Cabozantinib for previously treated advanced hepatocellular carcinomaTA849
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyTA850
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancerTA851
Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatmentsTA852
Esketamine nasal spray for treatment-resistant depressionTA854
PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetesMIB312
Memokath 051 Ureter stent for ureteric obstructionHTG651
Cemiplimab for untreated PD-L1-positive advanced or metastatic non-small-cell lung cancer (terminated appraisal)TA848
Mepolizumab for treating eosinophilic granulomatosis with polyangiitis (terminated appraisal)TA845
Mepolizumab for treating severe hypereosinophilic syndrome (terminated appraisal)TA846
Mepolizumab for treating severe chronic rhinosinusitis with nasal polyps (terminated appraisal)TA847
Optilume for treating recurrent bulbar urethral stricturesHTG649
GreenLight XPS for treating benign prostatic hyperplasiaHTG650
Luspatercept for treating anaemia caused by beta-thalassaemia (terminated appraisal)TA843
Luspatercept for treating anaemia caused by myelodysplastic syndromes (terminated appraisal)TA844
Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and managementNG228
Fractures (complex): assessment and managementNG37
Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosisHTG648
Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA841
Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal)TA842
Ab interno canaloplasty for open-angle glaucomaHTG647
Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal)TA840
Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodulesHTG646
Advocacy services for adults with health and social care needsNG227

Results per page

  1. 10
  2. 25
  3. 50
  4. All